Accession Number: | 0000899243-19-029765 |
Date: | 2019-12-18 |
Issuer: | EIDOS THERAPEUTICS, INC. (EIDX) |
Original Submission Date: |
SINHA UMA
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2000
SAN FRANCISCO, CA 94104
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-18 | S | 9,973 | d | $61.61 | 333,608 | direct | ||
COMMON STOCK | 2019-12-18 | S | 825 | d | $62.49 | 332,783 | direct | ||
COMMON STOCK | 2019-12-18 | S | 1,702 | d | $63.31 | 331,081 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents the weighted average sale price of the shares sold from $61.085 to $62.075 per share. the reporting person will provide, upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for all sales reported in footnotes 1 through 3. |
f2 | represents the weighted average sale price of the shares sold from $62.08 to $63.075 per share |
f3 | represents the weighted average sale price of the shares sold from $63.10 to $63.785 per share. |